(Press-News.org) Long-acting injectable cabotegravir (CAB-LA) was safe and well tolerated as HIV pre-exposure prophylaxis (PrEP) before and during pregnancy in the follow-up phase of a global study among cisgender women. The analysis of outcomes from more than 300 pregnancies and infants will be presented at the 2024 International AIDS Conference (AIDS 2024) in Munich, Germany.
“Cisgender women experience biological changes and social dynamics that can increase their likelihood of acquiring HIV during pregnancy and the postnatal period, and we need to offer them evidence-based options when they may need them most,” said Jeanne Marrazzo, M.D., M.P.H., director of the National Institutes of Health's (NIH) National Institute of Allergy and Infectious Diseases (NIAID). “These data provide reassurance about long-acting injectable cabotegravir for HIV prevention during pregnancy.”
CAB-LA is a highly effective HIV prevention method, administered by intramuscular injection every two months. However, data regarding the safety of CAB-LA during pregnancy are limited. An open-label extension study of the CAB-LA efficacy trial in cisgender women included women in several countries across East and Southern Africa who had the potential to become pregnant during the longitudinal study and who did not have HIV. Participants chose between CAB-LA or oral PrEP with tenofovir disoproxil fumarate and emtricitabine and had the option to use contraception if they wished. They were monitored closely for safety. Participants who became pregnant also were monitored for pregnancy-related adverse events including gestational hypertension, pre-eclampsia, and weight gain, as well as infant outcomes, such as miscarriage, intrauterine fetal death or stillbirth, premature birth, or low birthweight.
There were 367 pregnancies in this phase of the study. Pregnancy-related maternal adverse event incidence was 45.7, 47.1, and 37.5 per 100 person years among people using CAB-LA during pregnancy, prior to pregnancy, or with no CAB-LA use, respectively. Adverse infant outcomes were similar across groups, with negative outcomes reported in 33%, 38%, and 27% of pregnancies with CAB-LA use, prior CAB-LA use, or no CAB-LA use, respectively. One major congenital anomaly was reported in a participant receiving CAB-LA. No maternal deaths occurred. Pregnancy and infant outcomes in the study were similar to estimated general population outcomes.
Overall, CAB-LA was safe and well tolerated. These findings demonstrate the safety of using CAB-LA prior to and during pregnancy.
“The overlap between high HIV incidence and the specific risks that cisgender pregnant women face in acquiring HIV in many countries calls for diverse and highly effective PrEP options as part of sexual and reproductive health approaches,” said study chair Sinead Delany-Moretlwe, M.B.B.Ch., Ph.D., director of Research at Wits RHI and professor of Global Health and Infectious Diseases at the University of the Witwatersrand, Johannesburg. “We hope that these findings can fill an important knowledge gap that can help increase access to this highly effective HIV PrEP option among cisgender women before, during, and after pregnancy.”
This study is conducted and implemented by the NIH-funded HIV Prevention Trials Network (HPTN). NIAID sponsors and co-funds the trial with ViiV Healthcare and the Bill & Melinda Gates Foundation. ViiV Healthcare and Gilead Sciences, Inc., provide study medications. The NIH’s National Institute of Mental Health, National Institute on Drug Abuse, and Eunice Kennedy Shriver National Institute of Child Health and Human Development collaborated with NIAID on this study.
For more information about this trial, called HPTN 084, please visit ClinicalTrials.gov using the study identifier NCT03164564.
Reference:
S Delany-Moretlwe et al. Initial evaluation of injectable cabotegravir (CAB-LA) safety during pregnancy in the HPTN 084 open-label extension. International AIDS Conference. Thursday, July 25, 2024.
NIAID conducts and supports research—at NIH, throughout the United States, and worldwide—to study the causes of infectious and immune-mediated diseases, and to develop better means of preventing, diagnosing and treating these illnesses. News releases, fact sheets and other NIAID-related materials are available on the NIAID website.
About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit https://www.nih.gov/.
NIH...Turning Discovery Into Health®
END
CAMBRIDGE, MA – One thing that makes large language models (LLMs) so powerful is the diversity of tasks to which they can be applied. The same machine-learning model that can help a graduate student draft an email could also aid a clinician in diagnosing cancer.
However, the wide applicability of these models also makes them challenging to evaluate in a systematic way. It would be impossible to create a benchmark dataset to test a model on every type of question it can be asked.
In a new paper, MIT researchers took a different approach. They ...
Researchers working at the forefront of an emerging photovoltaic (PV) technology are thinking ahead about how to scale, deploy, and design future solar panels to be easily recyclable.
Solar panels made of perovskites may eventually play an important role amid global decarbonization efforts to reduce greenhouse gas emissions. As the technology emerges from the testing stages, it is a perfect time to think critically about how best to design the solar panels to minimize their impact on the environment decades from now.
“When you have a technology in its very early stages, you have the ability to design it better. It’s a cleaner slate,” said Joey Luther, a senior ...
Looking for a Medicare Advantage plan with a five-star quality rating? You’re less likely to find one available to you if you live in a county with higher poverty and unemployment, finds a new study published in JAMA Network Open.
These geographic disparities may be contributing to unequal health outcomes and limiting federal funds from reaching the regions most in need, according to the researchers.
“What this means is that Medicare beneficiaries living in counties with greater social disadvantage ...
The overarching goal of all carbon capture and storage projects is the same: Keep carbon dioxide (CO2) emissions out of the atmosphere by storing them in the subsurface for good.
One way to do that is to inject the CO2 into a reservoir space that’s covered with a big lid – an impermeable caprock that can keep the gas in place and stop any upward flow in its tracks. That’s the model that petroleum exploration has relied on for decades when searching for oil traps, and it works for both oil and CO2. But according to research led by The University of Texas at Austin’s Bureau of Economic Geology, subsurface ...
A new publication from Opto-Electronic Advances; DOI 10.29026/oea.2024.240036 , discusses sharp temperature reduction for quantum dots in polymer by highly efficient heat dissipation pathways.
Quantum dots (QDs), a kind of luminescent nanocrystals featuring size-tunable emission spectra and superior color purity are widely applied in optoelectronic fields. However, these particles are facing luminous efficiency degradation due to their temperature-sensitive characteristic and the high temperature in optoelectronic ...
A new automated system of monitoring and classifying persistent vibrations at active volcanoes can eliminate the hours of manual effort needed to document them.
Graduate student researcher Darren Tan at the University of Alaska Fairbanks Geophysical Institute led development of the system, which is based on machine learning. Machine learning is a branch of artificial intelligence focused on building systems that learn from data, identify patterns and make decisions with minimal human intervention.
Details about Tan’s automated ...
A new publication from Opto-Electronic Sciences; DOI 10.29026/oes.2024.240013 , discusses highly sensitive and real-simultaneous CH4/C2H2 dual-gas LITES sensor based on Lissajous pattern multi-pass cell.
Trace gases are atmospheric constituents with a volume fraction of less than 1%. Despite their low concentrations, nitrogen oxides, hydrocarbons, and sulfides in the atmosphere have a significant impact on the environment, closely related to phenomena such as acid rain, greenhouse effects, and ozone layer depletion. Therefore, race gas detection of is crucial for environmental ...
Genetic diversity is essential to the survival of a species. It’s easy enough to maintain if a species reproduces sexually; an egg and a sperm combine genetic material from two creatures into one, forming a genomically robust offspring with two distinct versions of the species’ genome.
Without that combination of different genetic makeups, asexually reproducing species typically suffer from a lack of diversity that can doom them to a limited run on Earth. One such animal should be the clonal raider ant, which produces daughter after genetically identical daughter directly from an unfertilized ovum ...
Scientists at Sanford Burnham Prebys, University of California San Diego and their international collaborators have reported that more types of lung cells can be infected by SARS-CoV-2 than previously thought, including those without known viral receptors. The research team also reported for the first time that the lung is capable of independently mustering an inflammatory antiviral response without help from the immune system when exposed to SARS-CoV-2.
This work is especially timely, as cases of COVID-19 are on the rise in the scientists’ hometown of San Diego during a summertime spike. Looking beyond the region, more than half of the states in the country have reported “very ...
WHAT:
Current or previous use of the antiretroviral drug (ARV) abacavir was associated with an elevated risk of major adverse cardiovascular events (MACE) in people with HIV, according to an exploratory analysis from a large international clinical trial primarily funded by the National Institutes of Health (NIH). There was no elevated MACE risk for the other antiretroviral drugs included in the analysis. The findings will be presented at the 2024 International AIDS Conference (AIDS 2024) in Munich, Germany.
The Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE) enrolled 7,769 study participants with HIV from 12 countries that found ...
